
Symbio Is Your Aesthetics CRO
With over 25 years of dermatology and aesthetic medicine expertise, Symbio is the specialized CRO you need to innovate, develop, and deliver next-generation aesthetic treatments. From dermal fillers and neurotoxins to advanced medical devices, we uphold the highest standards of scientific rigor, operational excellence, and regulatory compliance to reduce risk and uncertainty at every step.
Our Aesthetics Research Experience
We’ve supported aesthetics drugs, biologics, and devices across indications such as:
- Aging
- Botulinum toxins (neuromodulators)
- Cellulite
- Cheek augmentation
- Crow’s feet lines and glabellar lines
- Dermal fillers
- Forehead lines
- Infraorbital hollows
- Irritation
- Jaw line contouring
- Lip volume deficit
- Medical devices
- Midface & nasolabial folds
- Midface augmentation
- Midface volume deficit
- Oily skin
- PDO structures
- Photo aging
- Scarring/wound healing
- Sensitive skin
- Stretch mark treatments
- Submental fat
- Sun allergy
Three Flawless FDA Inspections and First CRO With MDR Annex XVI Approval for HA Dermal Fillers.
How Does Symbio Enhance Aesthetics Trials?
Symbio takes uncertainty out of aesthetics research with: